Cancer Care at the Crossroads 2016 Preliminary Program

A ONE-DAY INTERNATIONAL SUMMIT ON INNOVATION, CLINICAL BENEFIT AND COST

DATE & TIME

Friday,

March 25, 2016

7:45am - 4:30pm

LOCATION

New York Genome Center,

101 Avenue of the Americas,

New York, NY

OPENING REMARKS:
SETTING THE STAGE FOR THE DAY
7:45am - 8:00am

Mike Meyer

President, Meyer Consulting

Robert Darnell

MD, PhD Founding Director and CEO, New York Genome Center

ROUND TABLE 1
CANCER CARE DELIVERY AND COST THROUGH THE LENS OF HEALTH PLANS, ACADEMIC CENTERS, PHARMA AND PROVIDER GROUPS AND HOW THEY PERCEIVE EACH OTHER
8:00am - 9:15am

Moderator

Cheryl Moore

President and Chief Operating Officer, New York Genome Center

Speaker

Hal Paz

MD, Executive Vice President and Chief Medical Officer, Aetna

Speaker

Mace Rothenberg

MD, SVP, Clinical Development and Medical Affairs, Pfizer Oncology

Speaker

Jeffrey LeBenger

MD, Chairman and CEO, Summit Medical Group

Speaker

Richard Schilsky

MD, Chief Medical Officer, American Society of Clinical Oncology

ROUND TABLE 2
HOW TO INNOVATE AND LEVERAGE THE RESOURCES AND TALENT OF ACADEMIC MEDICAL CENTERS IN COLLABORATION WITH COMMUNITY PHYSICIANS
9:15am - 10:30am

Moderator

Mike Meyer

President, Meyer Consulting

Speaker

Alexander Eggermont

MD, PhD, Director General, Gustave Roussy; Chairman, Cancer Core Europe

Speaker

Andrew Norden

MD,CMO, Dana-Farber Community Cancer Care

Speaker

Margaret Row

MD, VP of Networks MD Anderson Cancer Center

Speaker

Jeffrey LeBenger

MD, Chairman and CEO, Summit Medical Group

MORNING BREAK
10:30am - 10:45am
ROUND TABLE 3
THE USE OF GENOMICS, PRECISION MEDICINE AND TARGETED THERAPIES TO IMPROVE QUALITY AND REDUCE COST OF CARE
10:45am - 12:00pm

Speaker

Gerald Batist

M.D., Professor and Director, Department of Oncology, McGill University; Director, McGill Centre for Translational Research in Cancer

Speaker

Stephen Emerson

MD, PhD, Professor and Director, Herbert Irving Comprehensive Cancer Center, NewYork-Presbyterian/Columbia University

Speaker

Mace Rothenberg

MD, SVP, Clinical Development and Medical Affairs, Pfizer Oncology

Speaker

Robert Darnell

MD, PhD Founding Director and CEO, New York Genome Center

Speaker

Razelle Kurzrock

MD, Senior Deputy Director, Moores Cancer Center, UCSD

LUNCH SERVED AT CONFERENCE CENTER
12:00pm - 1:00pm
ROUND TABLE 4
STRATEGIES/TOOLS FOR ASSESSING AND IMPROVING THE QUALITY OF CARE AND REDUCING COSTS
1:00pm - 2:00pm

Moderator

Glenn Pomerantz

MD, Chief Medical Officer, Horizon Blue Cross and Blue Shield

Speaker

Maureen Sullivan

Senior Vice President, Strategic Services and Chief Strategy Officer, Blue Cross and Blue Shield Association

Speaker

Elizabeth De Vries

MD, PhD, Head of Medical Oncology, University Medical Center, University of Groningen

Speaker

Andrew Pecora

MD, Chief Innovations Officer, Professor and Vice President of Cancer Services, John Theurer Cancer Center at Hackensack University Medical Center

ROUND TABLE 5
PUBLIC PERCEPTIONS OF CANCER TREATMENT, PREVENTION AND SURVIVORSHIP
2:00 - 3:00pm

Moderator

David Nanus

MD, Chief, Hematology/Medical Oncology, NewYork-Presbyterian/Weill Cornell; Associate Director, Meyer Cancer Center, Weill Cornell Medicine

Speaker

Robert Bazell

Professor, Yale University, Former Chief Health and Science Correspondent for NBC

Speaker

Frances M. Visco

JD, President, National Breast Cancer Coalition

Speaker

Lars Hjorth

MD, PhD, Consultant Pediatric Hematology / Oncology, Skane University Hospital, Lund University; Chairman, PanCare

AFTERNOON BREAK
3:00pm - 3:15pm
ROUND TABLE 6
THE CHALLENGES FACING HEALTH PLANS AND GOVERNMENTS IN FINANCING NEW INNOVATIVE TREATMENTS - ALTERNATIVE PAYMENT MODELS
3:15 - 4:30pm

Moderator

Jacque Sokolov

MD, Chairman and CEO, SSB Solutions

Speaker

Hal Paz

MD, Executive Vice President and Chief Medical Officer, Aetna

Speaker

Alexander Eggermont

MD, PhD, Director General, Gustave Roussy; Chairman, Cancer Core Europe

Speaker

Maureen Sullivan

Senior Vice President, Strategic Services and Chief Strategy Officer, Blue Cross and Blue Shield Association

Speaker

Indranil Bagchi

PhD, Vice President and Head, Payer Insights and Access, Global Health and Value, Pfizer

CLOSING REMARKS